Lek once again receives full Family Friendly Company certificate
- Lek Pharmaceuticals receives a full Family Friendly Company certificate for the second time in a row.
- Lek has been involved in the Family Friendly Company initiative from the very beginning of the project. It is one of the first companies in Slovenia to receive the full certificate. The certificate has been awarded for the tenth year in a row by a non-governmental organisation, the Ekvilib Institute.
- The Family Friendly Company certificate proves Lek's commitment to creating a work environment that is friendly to its employees and their families.
»For many years we have been committed to creating a work environment in which our employees would feel good and can effectively balance their professional and private life. At Lek, we adopt and adapt actions on the initiative of our employees and take care that they are actually executed in pratice,« said Marjan Novak, member of the Board of Management and Workers' Director on the occasion of the extension of the full Family Friendly Company certificate. Lek, celebrating 70 years of its existence this year, will continue its efforts to maintain the position of the employer of choice for employees with families, as this is an important part of their responsibility to employees.
Since Lek has become a Family Friendly Company holder, a number of family-friendly initiatives have been adopted, such as flexible work hours with a choice of arrival and departure time at the workplace, a time account, the option of working from home, re-integration of employees into work after maternity or parental leave, company open house days for families of employees, schoolchildren day care and leisure activities for children during school holidays. A few years ago, a new initiative was adopted - the child’s time bonus – which enables parents to take a day off when introducing children to a school or nursery. In addition, the subject of work-life integration has been included in the annual discussions about individual career development plans and a recommendation for the leaders was made to convene meetings with a planned commencement and completion within the fixed working hours (between 8.30 and 15.00).
Additional benefits are also available to employees, including the Lek kindergarten in Ljubljana, Christmas presents for associates’ children, different sports activities for associates, a fitness studio and health clinic at the company headquarters in Ljubljana, as well as further training and education. They encourage associates to live a healthy life-style with different activities throughout the whole year.
Employee satisfaction has been confirmed through the results of opinion polls among the employees and their active role in formulating proposals for new initiatives with which they want to co-create family-friendly conditions in the company.
Lek, a Sandoz company, is one of the key pillars of the second-largest generic pharmaceutical company globally. Its role within Sandoz is to act as: a leading global development center for technologically demanding products and technologies; a key global manufacturing center for active pharmaceutical ingredients and medicines; a competence center for the development of vertically integrated products; a Sandoz competence center in the field of development and manufacturing of biosimilar active ingredients and products; a supply center for the markets of Central and Eastern Europe (CEE), South East Europe (SEE) and the Commonwealth of Independent States (CIS), and is responsible for marketing and sales of Sandoz products on the Slovenian market. For further information, please visit www.lek.si.
Sandoz is a global leader in generic and biosimilar pharmaceuticals. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine. Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10.1 billion. In 2015, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.
Sandoz is on Twitter. Sign up to follow @Sandoz_global at http://twitter.com/Sandoz_Global (link is external).
For further details visit www.sandoz.com/makingaccesshappen
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world. For more information, please visit www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Katarina Klemenc
Corporate Communications
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
Fax: +386 1 580 24 32
katarina.klemenc@sandoz.com
Photo for print
Activities by year
Contact us
Gregor Makuc
T: +386 1 580 22 43
info.lek@sandoz.com